Our vision; To evolve the engagement model and elevate subnational market access
We're made up of a network of experienced senior leaders from Pharma and healthcare systems from the NHS. And we believe that subnational market access has to be as integral to your brand story. You may be missing the opportunity for your brand to reach its potential without fully engaging with this part of your healthcare system
Health Technology Appraisal (HTA) is the doorway to access, but it does not guarantee uptake. There also has to be clinical demand for your innovation. But subnational payers and systems will determine how easily your Healthcare Professionals can access you brand. A low position on a protocol, or a bottleneck in a service can't be fixed by engaging with clinicians alone, the subnational environment must also be unlocked.
We’re Missing Middle, because we believe there’s more the Pharmaceutical industry needs to do in subnational market access. Health Technology Appraisal and national influence pieces are crucial, and clinical advocacy is essential, but the increasingly influential subnational environment is often overlooked, disregarded, or ignored becau
We’re Missing Middle, because we believe there’s more the Pharmaceutical industry needs to do in subnational market access. Health Technology Appraisal and national influence pieces are crucial, and clinical advocacy is essential, but the increasingly influential subnational environment is often overlooked, disregarded, or ignored because it’s too complex. We simplify and help you understand subnational market access to fill the part of your brand strategy that’s missing.
Our expertise unlocks Subnational market access barriers to uptake. This is your key to reach the uptake in your brands forecast
We explain the complexity of subnational market access in a way you can truly understand it and apply it. We elevate the role of subnational market access by making sure your organisation understands the increasing influence of local payers
Working collaboratively has never been more important. With scarce resources in healthcare services, the luxury of speculative conversations is over. The pharmaceutical industry must add value beyond their medicine innovation. It’s not enough to only sell the medicine.
A conversation is the first step and carries no risk, and it could be the right step.
Copyright © 2023 Missing Middle - All Rights Reserved.
Powered by GoDaddy